Orbimed Advisors, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 06/24

Trade details

Type: Insider sale
Amount: $1,127,511.48
Shares · price: 24,846 sh · $45.38 a share
Held after: 220,882 sh
Stock: Enliven Therapeutics ELVN
Person: Orbimed Advisors10% Owner
Trade date: 26/06/22
Filed: 26/06/24
Days to filing: 2 days

Sold 10.1% of holdings

Share of holding sold: 10.1%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21

Orbimed Advisors, 10% Owner — sold $1.1M of Enliven Therapeutics ELVN · 10.1% of holdings | Whalegun